Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/ball_pits_web.jpg)
Pathogenic ball pits, zombie bacteria, and OTC beer
- Author:
- Lucas Franki
- Richard Franki
- Elena McPhillips
And heart failure patients could soon take a seat in the, ahem, oval office.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/fda_icon2_web.jpg)
FDA approves solriamfetol for daytime sleepiness treatment
- Author:
- Lucas Franki
Solriamfetol is the first dopamine and norepinephrine reuptake inhibitor approved to treat narcolepsy and obstructive sleep apnea.
News
Patients with OCD/hoarding differ from those with OCD/nonhoarding
- Author:
- Lucas Franki
“Clinical implications of our findings are to have the treatment follow a more intensive and structured course (i.e. avoid surprises).”
News
Biogen, Eisai discontinue aducanumab Alzheimer’s trials
- Author:
- Lucas Franki
All trials – the phase 3 ENGAGE and EMERGE trials, phase 2 EVOLVE safety study, and the long-term extension of the phase 1b PRIME study – have...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/ballot_box_web.jpg)
Sleepless democracy, space herpes, and the F-bomb diet
- Author:
- Lucas Franki
- Richard Franki
- Elena McPhillips
- Terry Rudd
And why you really, really do not want to lick surfaces on the International Space Station.
News
Disease burden in OA worse than RA 6 months post presentation
- Author:
- Lucas Franki
RAPID3 scores improved after 6 months for both RA and OA patients, but RA patients saw greater reductions.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_icon3_web.jpg)
FDA approves atezolizumab for first-line ES-SCLC treatment
- Author:
- Lucas Franki
Approval was based on improved overall survival demonstrated in the phase 3 IMpower133 study of 403 treatment-naive patients with extensive-stage...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/138740_graphic_web.png)
Match Day 2019: Dermatology steps up growth after slow 2018
- Author:
- Lucas Franki
Nearly all PGY-2 dermatology slots were filled in the 2019 Match.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/138746_graphic_web.png)
Match Day 2019: Psychiatry sees double-digit growth
- Author:
- Lucas Franki
Match Day 2019 was another record breaker, and psychiatry helped play a big role by offering nearly 200 more residency slots and matches than in...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Germs_cartoon.jpg)
Friendly gut bugs, MCI-battling mushrooms, and remembering to forget
- Author:
- Lucas Franki
- Richard Franki
- Elena McPhillips
And how one button-holing golfing great kept his health care funding on the fairway.
News
ACC to offer new certification for transcatheter valve repair, replacement
- Author:
- Lucas Franki
The Transcatheter Valve Certification will be launched in mid-2019.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/fda_icon2_web.jpg)
FDA approves new valsartan generic
- Author:
- Lucas Franki
FDA commissioner: “We’ve prioritized the review of generic applications for these valsartan products” to address angiotensin II receptor blocker...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_icon3_web.jpg)
FDA approves another trastuzumab biosimilar for HER2-positive breast cancer, gastric cancer
- Author:
- Lucas Franki
The Food and Drug Administration has approved Trazimera (trastuzumab-qyyp), a biosimilar of ...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/fda_icon2_web.jpg)
Dupilumab to undergo FDA Priority Review for CRSwNP treatment
- Author:
- Lucas Franki
The FDA will conduct a Priority Review on the supplemental Biologics License Application for dupilumab as an add...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/FDA_icon3_web.jpg)
FDA approves patient-controlled injector for guselkumab
- Author:
- Lucas Franki
The Food and Drug Administration has approved Tremfya (guselkumab) One-Press, a single-dose, patient-controlled...